AIM ImmunoTech Inc (AIM)
0.4048
0.00 (0.00%)
USD |
NYAM |
May 03, 16:00
0.4068
0.00 (0.00%)
After-Hours: 20:00
AIM ImmunoTech Cash from Investing (Quarterly): -0.214M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.214M |
| September 30, 2023 | -0.336M |
| June 30, 2023 | -0.204M |
| March 31, 2023 | -0.078M |
| December 31, 2022 | 3.363M |
| September 30, 2022 | 0.25M |
| June 30, 2022 | 7.721M |
| March 31, 2022 | -0.346M |
| December 31, 2021 | 0.364M |
| September 30, 2021 | -0.366M |
| June 30, 2021 | -1.152M |
| March 31, 2021 | 0.523M |
| December 31, 2020 | -0.182M |
| September 30, 2020 | -9.583M |
| June 30, 2020 | -3.082M |
| March 31, 2020 | 3.683M |
| December 31, 2019 | -5.289M |
| September 30, 2019 | -0.232M |
| June 30, 2019 | 0.472M |
| March 31, 2019 | -1.098M |
| December 31, 2018 | -1.518M |
| September 30, 2018 | 0.617M |
| June 30, 2018 | -0.043M |
| March 31, 2018 | 1.036M |
| December 31, 2017 | 1.087M |
| Date | Value |
|---|---|
| September 30, 2017 | 0.16M |
| June 30, 2017 | 0.997M |
| March 31, 2017 | 0.486M |
| December 31, 2016 | -0.027M |
| September 30, 2016 | 1.39M |
| June 30, 2016 | 1.613M |
| March 31, 2016 | -0.06M |
| December 31, 2015 | 4.269M |
| September 30, 2015 | 2.438M |
| June 30, 2015 | -0.163M |
| March 31, 2015 | -0.192M |
| December 31, 2014 | 1.881M |
| September 30, 2014 | 1.071M |
| June 30, 2014 | -0.243M |
| March 31, 2014 | -0.177M |
| December 31, 2013 | 9.271M |
| September 30, 2013 | 4.316M |
| June 30, 2013 | 3.512M |
| March 31, 2013 | 5.24M |
| December 31, 2012 | -11.00M |
| September 30, 2012 | -6.993M |
| June 30, 2012 | 0.287M |
| March 31, 2012 | 1.643M |
| December 31, 2011 | 1.585M |
| September 30, 2011 | 3.077M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-9.583M
Minimum
Sep 2020
7.721M
Maximum
Jun 2022
-0.2467M
Average
-0.204M
Median
Jun 2023
Cash from Investing (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -0.089M |
| Protalix BioTherapeutics Inc | -0.342M |
| Electromed Inc | -0.087M |
| Xtant Medical Holdings Inc | -2.313M |
| Armata Pharmaceuticals Inc | -2.39M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -9.758M |
| Cash from Financing (Quarterly) | 0.147M |
| Free Cash Flow | -21.85M |
| Free Cash Flow Per Share (Quarterly) | -0.2036 |
| Free Cash Flow to Equity (Quarterly) | -9.956M |
| Free Cash Flow Yield | -111.1% |